focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Mar 2022 07:00

RNS Number : 6733F
ReNeuron Group plc
23 March 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BF5G6K95

Issuer Name

RENEURON GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

21-Mar-2022

6. Date on which Issuer notified

22-Mar-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.734800

0.268700

1.003500

572650

Position of previous notification (if applicable)

0.734800

3.035000

3.769800

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF5G6K95

419300

0.734800

Sub Total 8.A

419300

0.734800%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

153350

0.268700

Sub Total 8.B1

153350

0.268700%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Alex Longmuir01727895161

12. Date of Completion

22-Mar-2022

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEANDAADFAEFA
Date   Source Headline
4th Dec 20157:00 amRNSNon-executive Director appointment
12th Nov 20152:45 pmRNSNotification of Interim Results
6th Nov 20153:29 pmRNSTotal Voting Rights
2nd Oct 20153:01 pmRNSDirectors' Interest in Shares and Share Options
28th Sep 201512:18 pmRNSBlock Admission and Total Voting Rights
24th Sep 20151:50 pmRNSResult of AGM
24th Sep 20157:00 amRNSAGM Trading Update
1st Sep 20153:22 pmRNSNotification of Major Interest in Shares
28th Aug 20152:45 pmRNSNotification of Major Interest in Shares
28th Aug 20157:00 amRNSNotification of Major Interest in Shares
27th Aug 20157:01 amRNSNotification of Major Interest in Shares
26th Aug 20157:30 amRNSNotification of Major Interest in Shares
26th Aug 20157:00 amRNSPosting of Annual Report and Notice of AGM
25th Aug 201510:00 amRNSCompletion of Placing and TVR
21st Aug 20151:45 pmRNSResult of General Meeting
29th Jul 20154:14 pmRNSPublication of Circular and Notice of GM
10th Jul 20157:01 amRNSPlacing to Raise £68.4 million
10th Jul 20157:00 amRNSPreliminary Results
22nd Jun 20157:00 amRNSExosome Research Collaboration
11th Jun 20157:00 amRNSSenior Management Appointments
29th May 20153:00 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
22nd May 20157:00 amRNSFDA Grants Fast Track Designation
15th May 20157:00 amRNSNotification of Major Interest in Shares
7th May 20157:00 amRNSNotification of Major Interest in Shares
5th May 20157:01 amRNSFDA Approves Start of Phase I/II Trial
22nd Apr 20154:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20154:35 pmRNSPrice Monitoring Extension
17th Apr 201512:15 pmRNSLong Term Clinical Data from PISCES Stroke Trial
13th Apr 20157:00 amRNSIND in the US
1st Apr 20157:00 amRNSReconfigures Board and Strengthens Executive Team
30th Jan 20157:00 amRNSDirector Share Purchases
13th Jan 20153:28 pmRNSNotification of Major Interest in Shares
8th Jan 20152:46 pmRNSNotification of Major Interest in Shares
17th Nov 20147:00 amRNSInterim Results
30th Oct 20147:00 amRNSNotification of Interim Results
14th Oct 20147:00 amRNSNotification of Major Interest in Shares
22nd Sep 20147:00 amRNSDirectors' Interest in Shares and Share Options
15th Sep 201412:15 pmRNSBlock Listing Six Monthly Review
8th Sep 20147:00 amRNSAppointment of CEO
3rd Sep 20147:00 amRNSNotification of Major Interest in Shares
2nd Sep 201411:30 amRNSResult of 2014 Annual General Meeting
2nd Sep 20147:00 amRNSAGM Trading Update
19th Aug 20149:00 amRNSNotification of Major Interest in Shares
25th Jul 20149:59 amRNSDirector/PDMR Shareholding
17th Jul 20149:00 amRNSPosting of Annual Report & Notice of AGM
24th Jun 20144:40 pmRNSSecond Price Monitoring Extn
24th Jun 20144:35 pmRNSPrice Monitoring Extension
20th Jun 20143:24 pmRNSNotification of Major Interest in Shares
20th Jun 20143:18 pmRNSNotification of Major Interest in Shares
18th Jun 20147:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.